A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis

Clinical trial NCT01706159 · TERMINATED

Trial details

NCT number: NCT01706159
Sponsor: Novo Nordisk A/S
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Inflammation Ulcerative Colitis

Start date: 2012-10-01
Primary completion: 2013-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.